| Title: |
A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence |
| Authors: |
Heumann, Thatcher R.Aff1; Baretti, MarinaAff1; Sugar, Elizabeth A.Aff1, Aff2; Durham, Jennifer N.Aff1; Linden, SheilaAff1; Lopez-Vidal, Tamara Y.Aff1; Leatherman, JamesAff1; Cope, LeslieAff1; Sharma, AnupAff1, Aff3; Weekes, Colin D.Aff4; O’Dwyer, Peter J.Aff5; Reiss, Kim A.Aff5; Monga, Dulabh K.Aff6; Ahuja, NitaAff1, Aff3; Azad, Nilofer S.Aff1, IDs13148022013678_cor15 |
| Source: |
Clinical Epigenetics. 14(1) |
| Database: |
Springer Nature Journals |